ACE and coronary artery disorder: Although the pharmacological treatment was not assessed, the first observational studies on patients with severe disease reported a high prevalence of comorbidities that are often treated with angiotensin converting enzyme (ACE) inhibitors, such as cerebrovascular diseases, coronary heart disease, hypertension and diabetes [2–4].